Form D — Inflammasome Therapeutics, Inc.
0001989925-26-000003 · filed 2026-05-04
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $13,155,645
- Total sold
- $13,155,645
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Inflammasome Therapeutics, Inc.
- CIK
- 1989925
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 57 CHAPEL ST.
NEWTON, MA 02458 - Phone
- 6173311071
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jayakrishna Ambati · Executive OfficerNEWTON, MA Find on LinkedIn ↗
-
Balamurali K. Ambati · Executive OfficerNEWTON, MA Find on LinkedIn ↗
-
Chaniyilparampu N. Ramchand · DirectorNEWTON, MA Find on LinkedIn ↗
-
Napoleone Ferrara · DirectorNEWTON, MA Find on LinkedIn ↗
-
Babur B. Lateef · DirectorNEWTON, MA Find on LinkedIn ↗
View original on SEC EDGAR.